Filing Details
- Accession Number:
- 0001076542-16-000399
- Form Type:
- 13G Filing
- Publication Date:
- 2016-09-22 12:39:04
- Filed By:
- Ballard Ralph
- Company:
- Nexeon Medsystems Inc
- Filing Date:
- 2016-09-22
- SEC Url:
- 13G Filing
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
---|---|---|---|---|---|---|
Ra | 1,026,723 | 0 | 1,026,723 | 0 | 1,026,723 | 5.18% |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. ________)*
NEXEON MEDSYSTEMS INC
(Name of Issuer)
Common Stock, $0.001 par value
(Title of Class of Securities)
65342G 104
(CUSIP Number)
Michael K. Hair, P.C.
7407 East Ironwood Court
Scottsdale, Arizona 85258
Phone: 480-443-9657
Fax: 480-443-1908
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
September 6, 2016
(Date of Event which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
☐ Rule 13d-1(b)
☒ Rule 13d-1(c)
☐ Rule 13d-1(d)
___________
* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
CUSIP No. 65342G 104 | 13G | Page 2 of 5 Pages | ||
1. | NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Ralph Ballard | |||
2. | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) ☐ (b) ☐ | |||
3. | SEC USE ONLY
| |||
4. | CITIZENSHIP OR PLACE OF ORGANIZATION
United States |
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: | 5. | SOLE VOTING POWER
1,026,723 (1) | ||
6. | SHARED VOTING POWER
0 | |||
7. | SOLE DISPOSITIVE POWER
1,026,723 (1) | |||
8. | SHARED DISPOSITIVE POWER
0 |
9. | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,026,723 (1) | |||
10. | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions) ☐
| |||
11. | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.18% (2) | |||
12. | TYPE OF REPORTING PERSON (see instructions)
IN | |||
(1) Includes 451,482 shares of Common Stock issuable upon the exercise of outstanding warrants. See Item 4, below. (2) Based upon 18,844,764 shares of the Company’s Common Stock issued and outstanding as reported by the Company in Amendment No. 2 to Form 10-12G Registration Statement filed on September 9, 2016. | ||||
CUSIP No. 65342G 104 | 13G | Page 3 of 5 Pages | ||
Item 1.
(a) | Name of Issuer
NEXEON MEDSYSTEMS INC(the “Company”) | |
(b) | Address of Issuer’s Principal Executive Offices
1708 Jaggie Fox Way Lexington, KY 40511 |
Item 2.
(a) | Name of Person Filing
Ralph Ballard | |
(b) | Address of the Principal Office or, if none, residence
1708 Jaggie Fox Way Lexington, KY 40511 | |
(c) | Citizenship
United States | |
(d) | Title of Class of Securities
Common Stock, $0.001 par value | |
(e) | CUSIP Number
65342G 104 |
Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a) | ☐ | Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). | |
(b) | ☐ | Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). | |
(c) | ☐ | Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). | |
(d) | ☐ | Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). | |
(e) | ☐ | An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); | |
(f) | ☐ | An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); | |
(g) | ☐ | A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G); | |
(h) | ☐ | A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); | |
(i) | ☐ | A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); | |
(j) | ☐ | Group, in accordance with §240.13d-1(b)(1)(ii)(J). |
CUSIP No. 65342G 104 | 13G | Page 4 of 5 Pages | ||
Item 4. Ownership.
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
(a) | Amount beneficially owned: Mr. Ballard currently beneficially owns 1,026,723 shares of Common Stock based on the following: | |||
(1) | 1,398 shares of Common Stock held by Mr. Ballard individually; | |||
(2) | 7,691 shares held by a Custodial IRA FBO Ralph Ballard. Mr. Ballard has the power to vote and dispose of the shares held by the Custodial IRA; | |||
(3) | 566,152 shares of Common Stock and 451,482 warrants to purchase 451,482 shares of Common Stock at a strike price of $2.00 per share with a term of 36 months held by Ballard Investments, Inc., a West Virginia corporation. The warrants are currently exercisable and expire on February 16, 2018. Mr. Ballard has the power to vote and dispose of the shares and warrants held by Ballard Investments. Inc. |
In addition, three trusts representing three of Mr. Ballard’s children hold a total of 427,075 shares of Common Stock and 427,075 warrants to purchase 427,075 shares of Common Stock at a strike price of $2.00 per share with a term of 36 months, divided between and issued to the three trusts. The warrants are currently exercisable and expire on February 16, 2018. The three trusts are irrevocable trusts managed by an arms-length third party professional fiduciary. Mr. Ballard disclaims any beneficial ownership in the Common Stock and warrants issued to the three trusts and such shares are not included in the total shares beneficially owned by Mr. Ballard. |
(b) | Percent of class: 5.18%, based upon 18,844,764 shares of the Company’s Common Stock issued and outstanding as reported by the Company in Amendment No. 2 to Form 10-12G Registration Statement filed on September 9, 2016. | |||
(c) | Number of shares as to which the person has: | |||
(i) | Sole power to vote or to direct the vote 1,026,723 | |||
(ii) | Shared power to vote or to direct the vote 0 | |||
(iii) | Sole power to dispose or to direct the disposition of 1,026,723 | |||
(iv) | Shared power to dispose or to direct the disposition of 0 |
Item 5. Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☐.
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
Not applicable.
CUSIP No. 65342G 104 | 13G | Page 5 of 5 Pages | ||
Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.
Not applicable.
Item 8. Identification and Classification of Members of the Group.
Not applicable.
Item 9. Notice of Dissolution of Group.
Not applicable.
Item 10. Certification.
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date: September 21, 2016 | /s/ Ralph Ballard | |
Ralph Ballard |